Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings.

× No keyword cloud information.

2 in total

1. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.

Authors: P J Barrett; P D Emmins; P D Clarke; D J Bradley
Journal: BMJ Date: 1996-08-31

2. Malaria prophylaxis. Mefloquine toxicity should limit its use to treatment alone.

Authors: G C Cook
Journal: BMJ Date: 1995-07-15

2 in total

5 in total

1. A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons.

Authors: Robert Tansley; Julie Lotharius; Anthony Priestley; Fiona Bull; Stephan Duparc; Jörg Möhrle
Journal: Am J Trop Med Hyg Date: 2010-12 Impact factor: 2.345

2. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.

Authors: Christoph R Meier; Karen Wilcock; Susan S Jick
Journal: Drug Saf Date: 2004 Impact factor: 5.606

Review 3. WITHDRAWN: Mefloquine for preventing malaria in non-immune adult travellers.

Authors: A M J Croft; P Garner
Journal: Cochrane Database Syst Rev Date: 2008-01-23

Review 4. Mefloquine for preventing malaria during travel to endemic areas.

Authors: Maya Tickell-Painter; Nicola Maayan; Rachel Saunders; Cheryl Pace; David Sinclair
Journal: Cochrane Database Syst Rev Date: 2017-10-30

5. Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.

Authors: Mary A Bitta; Symon M Kariuki; Clifford Mwita; Samson Gwer; Leah Mwai; Charles R J C Newton
Journal: Wellcome Open Res Date: 2017-06-02

5 in total